Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

BTBD9 Antikörper (AA 200-400)

Der Maus Monoklonal anti-BTBD9 Antikörper wird verwendet zum Nachweis von BTBD9 in Proben von Human. Er wurde validiert für IHC.
Produktnummer ABIN7859463
639,45 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 10 Werktagen

Kurzübersicht für BTBD9 Antikörper (AA 200-400) (ABIN7859463)

Target

Alle BTBD9 Antikörper anzeigen
BTBD9 (BTB (POZ) Domain Containing 9 (BTBD9))

Reaktivität

  • 18
  • 2
  • 1
Human

Wirt

  • 12
  • 6
Maus

Klonalität

  • 15
  • 3
Monoklonal

Konjugat

  • 13
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser BTBD9 Antikörper ist unkonjugiert

Applikation

  • 16
  • 10
  • 9
  • 9
  • 2
  • 1
  • 1
Immunohistochemistry (IHC)

Klon

BTBD9-7501
  • Bindungsspezifität

    • 8
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 200-400

    Verwendungszweck

    BTBD9 Antibody

    Spezifität

    BTBD9 (BTB/POZ domain-containing protein 9) is a 612 amino acid protein that contains one BTB/POZ domain and one BACK (BTB/Kelch associated) domain. The BTB/POZ domain mediates homomeric and heteromeric POZPOZ interactions and is common to transcriptional regulators involved in chromatin modeling. In several BTB/POZ containing proteins, including Bcl-6 and the promyelocytic leukemia zinc-finger (PLZF) oncoprotein, this domain interacts with the SMRT/N-CoR-mSin3A HDAC complex and is directly involved in repressing and silencing gene transcription. When this domain is deleted, as with the oncogenic PLZF-RAR chimera of promyelocytic leukemias, this transcriptional repression is attenuated. This suggests that BTBD9 may play a role in transcription regulation. Genetic variations in the gene that encodes BTBD9 have been associated with susceptibility to restless legs syndrome type 6 (RLS6), a condition characterized by an uncontrollable urge to move the legs while resting.

    Aufreinigung

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogen

    Recombinant fragment (around aa200-400) of human BTBD9 protein (exact sequence is proprietary)

    Isotyp

    IgG1, kappa
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10  mM PBS

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
  • Target

    BTBD9 (BTB (POZ) Domain Containing 9 (BTBD9))

    Andere Bezeichnung

    BTBD9

    Hintergrund

    BTB/POZ domain-containing protein 9

    Human fallopian tube|lung or lymph node.

    Molekulargewicht

    69kDa

    Gen-ID

    114781, 603858

    UniProt

    Q96Q07

    Pathways

    Transition Metal Ion Homeostasis
Sie sind hier:
Chat with us!